{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:07:15Z","timestamp":1789992435096,"version":"4.0.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s10194-019-0979-y","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T13:13:43Z","timestamp":1552482823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?"],"prefix":"10.1186","volume":"20","author":[{"name":"European Headache Federation School of Advanced Studies (EHF-SAS)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-2438","authenticated-orcid":false,"given":"Valentina","family":"Favoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Al-Hassany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Asioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogera","family":"Butera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Guglielmetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysoula","family":"Koniari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Mavridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marge","family":"Vaikj\u00e4rv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Verzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Zick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"979_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-14-1","volume":"14","author":"TJ Steiner","year":"2013","unstructured":"Steiner TJ, Stovner LJ, Birbeck GL (2013 Jan 10) Migraine: the seventh disabler. J Headache Pain 14:1","journal-title":"J Headache Pain"},{"issue":"10100","key":"979_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017 Sep 16) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211\u20131259","journal-title":"Lancet"},{"issue":"Suppl 2","key":"979_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/head.13081","volume":"57","author":"L Edvinsson","year":"2017","unstructured":"Edvinsson L (2017 May) The Trigeminovascular pathway: role of CGRP and CGRP receptors in migraine. Headache. 57(Suppl 2):47\u201355","journal-title":"Headache."},{"issue":"6","key":"979_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN (2018 Jun) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 14(6):338\u2013350","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"979_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1468-2982.2008.01675.x","volume":"28","author":"L Edvinsson","year":"2008","unstructured":"Edvinsson L, Tfelt-Hansen P (2008 Dec) The blood-brain barrier in migraine treatment. Cephalalgia. 28(12):1245\u20131258","journal-title":"Cephalalgia."},{"key":"979_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","volume":"1600","author":"S Eftekhari","year":"2015","unstructured":"Eftekhari S, Salvatore CA, Johansson S, Chen T-B, Zeng Z, Edvinsson L (2015 Mar 10) Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier. Brain Res 1600:93\u2013109","journal-title":"Brain Res"},{"issue":"9","key":"979_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.tips.2016.06.002","volume":"37","author":"A MaassenVanDenBrink","year":"2016","unstructured":"MaassenVanDenBrink A, Meijer J, Villal\u00f3n CM, Ferrari MD, Wiping Out CGRP (2016) Potential Cardiovascular Risks. Trends Pharmacol Sci 37(9):779\u2013788","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"979_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-0115(86)90071-6","volume":"15","author":"R Uddman","year":"1986","unstructured":"Uddman R, Edvinsson L, Ekblad E, H\u00e5kanson R, Sundler F (1986 Aug) Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept 15(1):1\u201323","journal-title":"Regul Pept"},{"issue":"3","key":"979_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/01.RES.73.3.579","volume":"73","author":"S Gulbenkian","year":"1993","unstructured":"Gulbenkian S, Saetrum Opgaard O, Ekman R, Costa Andrade N, Wharton J, Polak JM et al (1993 Sep) Peptidergic innervation of human epicardial coronary arteries. Circ Res 73(3):579\u2013588","journal-title":"Circ Res"},{"issue":"2","key":"979_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622","journal-title":"Physiol Rev"},{"issue":"4","key":"979_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie S-J, Kodji X, Brain SD (2014 Oct) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94(4):1099\u20131142","journal-title":"Physiol Rev"},{"issue":"1","key":"979_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","volume":"25","author":"PK Mulderry","year":"1988","unstructured":"Mulderry PK, Ghatei MA, Spokes RA, Jones PM, Pierson AM, Hamid QA et al (1988 Apr) Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience. 25(1):195\u2013205","journal-title":"Neuroscience."},{"issue":"2","key":"979_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/bcp.12618","volume":"80","author":"L Edvinsson","year":"2015","unstructured":"Edvinsson L (2015 Aug) CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol 80(2):193\u2013199","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"979_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0165-6147(00)01555-8","volume":"21","author":"C Juaneda","year":"2000","unstructured":"Juaneda C, Dumont Y, Quirion R (2000 Nov) The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci 21(11):432\u2013438","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"979_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0196-9781(85)90178-0","volume":"6","author":"G Skofitsch","year":"1985","unstructured":"Skofitsch G, Jacobowitz DM (1985 Jul-Aug) Calcitonin gene-related peptide: detailed immunohistochemical distribution in the central nervous system. Peptides. 6(4):721\u2013745","journal-title":"Peptides."},{"issue":"11","key":"979_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","volume":"14","author":"S Eftekhari","year":"2013","unstructured":"Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L (2013 Nov) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain 14(11):1289\u20131303","journal-title":"J Pain"},{"key":"979_CR17","first-page":"333102417736900","volume":"1","author":"L Edvinsson","year":"2017","unstructured":"Edvinsson L, Warfvinge K (2017 Jan) Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Cephalalgia. 1:333102417736900","journal-title":"Cephalalgia."},{"issue":"4692","key":"979_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.2983422","volume":"227","author":"D Goltzman","year":"1985","unstructured":"Goltzman D, Mitchell J (1985 Mar) Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science. 227(4692):1343\u20131345","journal-title":"Science."},{"issue":"4","key":"979_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/head.13064","volume":"57","author":"DL Hay","year":"2017","unstructured":"Hay DL, Walker CS (2017 Apr) CGRP and its receptors. Headache. 57(4):625\u2013636","journal-title":"Headache."},{"issue":"1","key":"979_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","volume":"175","author":"DL Hay","year":"2018","unstructured":"Hay DL, Garelja ML, Poyner DR, Walker CS (2018) Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR review 25. Br J Pharmacol 175(1):3\u201317","journal-title":"Br J Pharmacol"},{"issue":"5","key":"979_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1210\/edrv-17-5-533","volume":"17","author":"SJ Wimalawansa","year":"1996","unstructured":"Wimalawansa SJ (1996 Oct) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17(5):533\u2013585","journal-title":"Endocr Rev"},{"issue":"40","key":"979_CR22","doi-asserted-by":"publisher","first-page":"31438","DOI":"10.1074\/jbc.M005604200","volume":"275","author":"BN Evans","year":"2000","unstructured":"Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM (2000 Oct 6) CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 275(40):31438\u201331443","journal-title":"J Biol Chem"},{"issue":"5","key":"979_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","volume":"22","author":"KR Oliver","year":"2002","unstructured":"Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG (2002 May) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22(5):620\u2013629","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"979_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","volume":"169","author":"S Eftekhari","year":"2010","unstructured":"Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L (2010 Aug 25) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience. 169(2):683\u2013696","journal-title":"Neuroscience."},{"issue":"4","key":"979_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0891-0618(91)90020-D","volume":"4","author":"JW Unger","year":"1991","unstructured":"Unger JW, Lange W (1991 Aug) Immunohistochemical mapping of neurophysins and calcitonin gene-related peptide in the human brainstem and cervical spinal cord. J Chem Neuroanat 4(4):299\u2013309","journal-title":"J Chem Neuroanat"},{"key":"979_CR26","first-page":"333102417728873","volume":"1","author":"K Warfvinge","year":"2017","unstructured":"Warfvinge K, Edvinsson L (2017 Jan) Distribution of CGRP and CGRP receptor components in the rat brain. Cephalalgia. 1:333102417728873","journal-title":"Cephalalgia."},{"issue":"2","key":"979_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0304-3940(85)90166-1","volume":"58","author":"L Edvinsson","year":"1985","unstructured":"Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C (1985 Jul 31) Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 58(2):213\u2013217","journal-title":"Neurosci Lett"},{"issue":"3","key":"979_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1152\/physrev.00037.2003","volume":"84","author":"SD Brain","year":"2004","unstructured":"Brain SD, Grant AD (2004 Jul) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84(3):903\u2013934","journal-title":"Physiol Rev"},{"issue":"3","key":"979_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1476-5381.1992.tb14508.x","volume":"107","author":"DW Gray","year":"1992","unstructured":"Gray DW, Marshall I (1992 Nov) Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 107(3):691\u2013696","journal-title":"Br J Pharmacol"},{"key":"979_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1129-2377-14-80","volume":"14","author":"S Sacco","year":"2013","unstructured":"Sacco S, Ripa P, Grassi D, Pistoia F, Ornello R, Carolei A et al (2013 Oct 1) Peripheral vascular dysfunction in migraine: a review. J Headache Pain. 14:80","journal-title":"J Headache Pain."},{"issue":"4","key":"979_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/apha.12213","volume":"210","author":"L Edvinsson","year":"2014","unstructured":"Edvinsson L, Ahnstedt H, Larsen R, Sheykhzade M (2014 Apr) Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries. Acta Physiol (Oxf). 210(4):811\u2013822","journal-title":"Acta Physiol (Oxf)."},{"issue":"5","key":"979_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1468-2982.2008.01558.x","volume":"28","author":"ML Edvinsson","year":"2008","unstructured":"Edvinsson ML, Edvinsson L (2008 May) Comparison of CGRP and NO responses in the human peripheral microcirculation of migraine and control subjects. Cephalalgia. 28(5):563\u2013566","journal-title":"Cephalalgia."},{"key":"979_CR33","doi-asserted-by":"publisher","first-page":"b3914","DOI":"10.1136\/bmj.b3914","volume":"339","author":"M Sch\u00fcrks","year":"2009","unstructured":"Sch\u00fcrks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009 Oct 27) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 339:b3914","journal-title":"BMJ."},{"issue":"9","key":"979_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11886-014-0524-1","volume":"16","author":"S Sacco","year":"2014","unstructured":"Sacco S, Kurth T (2014 Sep) Migraine and the risk for stroke and cardiovascular disease. Curr Cardiol Rep 16(9):524","journal-title":"Curr Cardiol Rep"},{"key":"979_CR35","doi-asserted-by":"publisher","first-page":"i2610","DOI":"10.1136\/bmj.i2610","volume":"353","author":"T Kurth","year":"2016","unstructured":"Kurth T, Winter AC, Eliassen AH, Dushkes R, Mukamal KJ, Rimm EB et al (2016 May 31) Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 353:i2610","journal-title":"BMJ."},{"issue":"6","key":"979_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ene.12701","volume":"22","author":"S Sacco","year":"2015","unstructured":"Sacco S, Ornello R, Ripa P, Tiseo C, Degan D, Pistoia F et al (2015 Jun) Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur J Neurol 22(6):1001\u20131011","journal-title":"Eur J Neurol"},{"issue":"11","key":"979_CR37","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1161\/STROKEAHA.113.002465","volume":"44","author":"S Sacco","year":"2013","unstructured":"Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A (2013 Nov) Migraine and hemorrhagic stroke: a meta-analysis. Stroke. 44(11):3032\u20133038","journal-title":"Stroke."},{"issue":"10","key":"979_CR38","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0333102412451361","volume":"32","author":"S Sacco","year":"2012","unstructured":"Sacco S, Ricci S, Carolei A (2012 Jul) Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia. 32(10):785\u2013795","journal-title":"Cephalalgia."},{"issue":"3","key":"979_CR39","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0006-291X(88)80481-9","volume":"151","author":"Y Hirata","year":"1988","unstructured":"Hirata Y, Takagi Y, Takata S, Fukuda Y, Yoshimi H, Fujita T (1988 Mar 30) Calcitonin gene-related peptide receptor in cultured vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 151(3):1113\u20131121","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"979_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1476-5381.1990.tb14656.x","volume":"99","author":"DC Crossman","year":"1990","unstructured":"Crossman DC, Dashwood MR, Brain SD, McEwan J, Pearson JD (1990 Jan) Action of calcitonin gene-related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co-culture. Br J Pharmacol 99(1):71\u201376","journal-title":"Br J Pharmacol"},{"issue":"4","key":"979_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/1523-1747.ep12455620","volume":"87","author":"SD Brain","year":"1986","unstructured":"Brain SD, Tippins JR, Morris HR, MacIntyre I, Williams TJ (1986 Oct) Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol 87(4):533\u2013536","journal-title":"J Invest Dermatol"},{"issue":"2","key":"979_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1468-2982.2004.00830.x","volume":"25","author":"KA Petersen","year":"2005","unstructured":"Petersen KA, Birk S, Lassen LH, Kruuse C, Jonassen O, Lesko L et al (2005 Feb) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia. 25(2):139\u2013147","journal-title":"Cephalalgia."},{"issue":"1","key":"979_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1210\/endo-119-1-381","volume":"119","author":"S Sigrist","year":"1986","unstructured":"Sigrist S, Franco-Cereceda A, Muff R, Henke H, Lundberg JM, Fischer JA (1986 Jul) Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology. 119(1):381\u2013389","journal-title":"Endocrinology."},{"issue":"6","key":"979_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF02554909","volume":"37","author":"C Gennari","year":"1985","unstructured":"Gennari C, Fischer JA (1985 Dec) Cardiovascular action of calcitonin gene-related peptide in humans. Calcif Tissue Int 37(6):581\u2013584","journal-title":"Calcif Tissue Int"},{"issue":"2 Pt 2","key":"979_CR45","first-page":"R332","volume":"256","author":"SM Gardiner","year":"1989","unstructured":"Gardiner SM, Compton AM, Bennett T (1989 Feb) Regional hemodynamic effects of calcitonin gene-related peptide. Am J Phys 256(2 Pt 2):R332\u2013R338","journal-title":"Am J Phys"},{"issue":"2 Pt 2","key":"979_CR46","first-page":"R421","volume":"256","author":"X Wang","year":"1989","unstructured":"Wang X, Fiscus RR (1989 Feb) Calcitonin gene-related peptide increases cAMP, tension, and rate in rat atria. Am J Phys 256(2 Pt 2):R421\u2013R428","journal-title":"Am J Phys"},{"issue":"2 Pt 2","key":"979_CR47","first-page":"R425","volume":"258","author":"K Ando","year":"1990","unstructured":"Ando K, Pegram BL, Frohlich ED (1990 Feb) Hemodynamic effects of calcitonin gene-related peptide in spontaneously hypertensive rats. Am J Phys 258(2 Pt 2):R425\u2013R429","journal-title":"Am J Phys"},{"issue":"12","key":"979_CR48","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/00004872-199210120-00010","volume":"10","author":"A Masuda","year":"1992","unstructured":"Masuda A, Shimamoto K, Mori Y, Nakagawa M, Ura N, Iimura O (1992 Dec) Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases. J Hypertens 10(12):1499\u20131504","journal-title":"J Hypertens"},{"issue":"10","key":"979_CR49","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/00004872-199210000-00017","volume":"10","author":"F Portaluppi","year":"1992","unstructured":"Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R et al (1992 Oct) Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J Hypertens 10(10):1227\u20131234","journal-title":"J Hypertens"},{"issue":"5","key":"979_CR50","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.113.02517","volume":"63","author":"S-J Smillie","year":"2014","unstructured":"Smillie S-J, King R, Kodji X, Outzen E, Pozsgai G, Fernandes E et al (2014 May) An ongoing role of \u03b1-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress. Hypertension. 63(5):1056\u20131062","journal-title":"Hypertension."},{"issue":"3","key":"979_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/cvr\/24.3.239","volume":"24","author":"C Gennari","year":"1990","unstructured":"Gennari C, Nami R, Agnusdei D, Fischer JA (1990 Mar) Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure. Cardiovasc Res 24(3):239\u2013241","journal-title":"Cardiovasc Res"},{"issue":"1","key":"979_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/apha.12244","volume":"211","author":"B Schuler","year":"2014","unstructured":"Schuler B, Rieger G, Gubser M, Arras M, Gianella M, Vogel O et al (2014 May) Endogenous \u03b1-calcitonin-gene-related peptide promotes exercise-induced, physiological heart hypertrophy in mice. Acta Physiol (Oxf) 211(1):107\u2013121","journal-title":"Acta Physiol (Oxf)"},{"issue":"2\u20133","key":"979_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0014-2999(94)00653-O","volume":"272","author":"AJ D\u2019Alonzo","year":"1995","unstructured":"D\u2019Alonzo AJ, Grover GJ, Darbenzio RB, Hess TA, Sleph PG, Dzwonczyk S et al (1995 Jan 16) In vitro effects of capsaicin: antiarrhythmic and antiischemic activity. Eur J Pharmacol 272(2\u20133):269\u2013278","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"979_CR54","first-page":"445","volume":"17","author":"ZS Xiao","year":"1996","unstructured":"Xiao ZS, Li YJ, Deng HW (1996 Sep) Ischemic preconditioning mediated by calcitonin gene-related peptide in isolated rat hearts. Zhongguo Yao Li Xue Bao 17(5):445\u2013448","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"1\u20133","key":"979_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejphar.2005.12.039","volume":"531","author":"W Chai","year":"2006","unstructured":"Chai W, Mehrotra S, Jan Danser AH, Schoemaker RG (2006 Feb 15) The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts. Eur J Pharmacol 531(1\u20133):246\u2013253","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"979_CR56","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/HJH.0000000000001649","volume":"36","author":"L Zhai","year":"2018","unstructured":"Zhai L, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Tanaka M et al (2018 Apr) Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline. J Hypertens 36(4):876\u2013891","journal-title":"J Hypertens"},{"issue":"1","key":"979_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-3940(94)90240-2","volume":"170","author":"R Juul","year":"1994","unstructured":"Juul R, Aakhus S, Bj\u00f6rnstad K, Gisvold SE, Brubakk AO, Edvinsson L (1994 Mar 28) Calcitonin gene-related peptide (human alpha-CGRP) counteracts vasoconstriction in human subarachnoid haemorrhage. Neurosci Lett 170(1):67\u201370","journal-title":"Neurosci Lett"},{"issue":"4","key":"979_CR58","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jocn.2012.07.006","volume":"20","author":"K-M Schebesch","year":"2013","unstructured":"Schebesch K-M, Herbst A, Bele S, Sch\u00f6del P, Brawanski A, Stoerr E-M et al (2013 Apr) Calcitonin-gene related peptide and cerebral vasospasm. J Clin Neurosci 20(4):584\u2013586","journal-title":"J Clin Neurosci"},{"key":"979_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejphar.2019.01.007","volume":"846","author":"SE Johansson","year":"2019","unstructured":"Johansson SE, Abdolalizadeh B, Sheykhzade M, Edvinsson L, Sams A (2019 Mar 5) Vascular pathology of large cerebral arteries in experimental subarachnoid hemorrhage: vasoconstriction, functional CGRP depletion and maintained CGRP sensitivity. Eur J Pharmacol 846:109\u2013118","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"979_CR60","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/00365519009091595","volume":"50","author":"S Valdemarsson","year":"1990","unstructured":"Valdemarsson S, Edvinsson L, Hedner P, Ekman R (1990 Jun) Hormonal influence on calcitonin gene-related peptide in man: effects of sex difference and contraceptive pills. Scand J Clin Lab Invest 50(4):385\u2013388","journal-title":"Scand J Clin Lab Invest"},{"issue":"11","key":"979_CR61","doi-asserted-by":"publisher","first-page":"H1525","DOI":"10.1152\/ajpheart.00874.2012","volume":"304","author":"M Al-Rubaiee","year":"2013","unstructured":"Al-Rubaiee M, Gangula PR, Millis RM, Walker RK, Umoh NA, Cousins VM et al (2013 Jun 1) Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart. Am J Physiol Heart Circ Physiol 304(11):H1525\u2013H1537","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"979_CR62","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1095\/biolreprod.102.007682","volume":"67","author":"PRR Gangula","year":"2002","unstructured":"Gangula PRR, Wimalawansa SJ, Yallampalli C (2002 Dec) Sex steroid hormones enhance hypotensive effects of calcitonin gene-related peptide in aged female rats. Biol Reprod 67(6):1881\u20131887","journal-title":"Biol Reprod"},{"issue":"2","key":"979_CR63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1526-4610.2006.00526.x","volume":"47","author":"S Gupta","year":"2007","unstructured":"Gupta S, Villal\u00f3n CM, Mehrotra S, de Vries R, Garrelds IM, Saxena PR et al (2007 Feb) Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin. Headache. 47(2):225\u2013235","journal-title":"Headache."},{"key":"979_CR64","doi-asserted-by":"publisher","first-page":"632461","DOI":"10.1155\/2013\/632461","volume":"2013","author":"RL Westley","year":"2013","unstructured":"Westley RL, May FEB (2013) A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors. Int J Endocrinol 2013:632461","journal-title":"Int J Endocrinol"},{"key":"979_CR65","first-page":"333102417739584","volume":"1","author":"A Labastida-Ram\u00edrez","year":"2017","unstructured":"Labastida-Ram\u00edrez A, Rubio-Beltr\u00e1n E, Villal\u00f3n CM, MaassenVanDenBrink A (2017) Gender aspects of CGRP in migraine. Cephalalgia. 1:333102417739584","journal-title":"Cephalalgia."},{"key":"979_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/WNL.0000000000001142","volume":"84","author":"K Ibrahimi","year":"2015","unstructured":"Ibrahimi K, van Oosterhout WP, van Dorp W et al (2015) Reduced trigeminovascular cyclicity in patients with menstrually related migraine. Neurology 84:125\u2013131","journal-title":"Neurology"},{"issue":"12","key":"979_CR67","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1177\/0333102416668659","volume":"37","author":"K Ibrahimi","year":"2017","unstructured":"Ibrahimi K, Vermeersch S, Frederiks P, Geldhof V, Draulans C, Buntinx L, de Hoon J (2017) The influence of migraine and female hormones on capsaicin-induced dermal blood flow. Cephalalgia 37(12):1164\u20131172","journal-title":"Cephalalgia"},{"issue":"3","key":"979_CR68","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","volume":"129","author":"H Doods","year":"2000","unstructured":"Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W et al (2000 Feb) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129(3):420\u2013423","journal-title":"Br J Pharmacol"},{"issue":"11","key":"979_CR69","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener H-C, Husstedt IW, Goadsby PJ, Hall D, Meier U et al (2004 Mar 11) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350(11):1104\u20131110","journal-title":"N Engl J Med"},{"issue":"7","key":"979_CR70","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/bjp.2008.334","volume":"155","author":"J Zeller","year":"2008","unstructured":"Zeller J, Poulsen KT, Sutton JE, Abdiche YN, Collier S, Chopra R et al (2008 Dec) CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. Br J Pharmacol 155(7):1093\u20131103","journal-title":"Br J Pharmacol"},{"issue":"6","key":"979_CR71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1742-7843.2004.pto940606.x","volume":"94","author":"U Arulmani","year":"2004","unstructured":"Arulmani U, Schuijt MP, Heiligers JPC, Willems EW, Villal\u00f3n CM, Saxena PR (2004 Jun) Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats. Basic Clin Pharmacol Toxicol 94(6):291\u2013297","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1\u20133","key":"979_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0014-2999(03)02082-X","volume":"475","author":"K Kapoor","year":"2003","unstructured":"Kapoor K, Arulmani U, Heiligers JPC, Willems EW, Doods H, Villal\u00f3n CM et al (2003 Aug 15) Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig. Eur J Pharmacol 475(1\u20133):69\u201377","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"979_CR73","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1124\/jpet.108.144220","volume":"328","author":"CP Regan","year":"2009","unstructured":"Regan CP, Stump GL, Kane SA, Lynch JJ (2009 Feb) Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis. J Pharmacol Exp Ther 328(2):571\u2013578","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"979_CR74","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1365-2125.2010.03869.x","volume":"71","author":"BJ Schueren Van der","year":"2011","unstructured":"Van der Schueren BJ, Blanchard R, Murphy MG, Palcza J, De Lepeleire I, Van Hecken A et al (2011 May) The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men. Br J Clin Pharmacol 71(5):708\u2013717","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"979_CR75","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/clpt.2011.246","volume":"91","author":"BR Chaitman","year":"2012","unstructured":"Chaitman BR, Ho AP, Behm MO, Rowe JF, Palcza JS, Laethem T et al (2012 Mar) A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina. Clin Pharmacol Ther 91(3):459\u2013466","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"979_CR76","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/papr.12158","volume":"15","author":"X Cui","year":"2015","unstructured":"Cui X, Ye J, Lin H, Mu J, Lin M (2015 Feb) Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis. Pain Pract 15(2):124\u2013131","journal-title":"Pain Pract"},{"issue":"3","key":"979_CR77","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.pharmthera.2010.12.001","volume":"129","author":"KY Chan","year":"2011","unstructured":"Chan KY, Vermeersch S, de Hoon J, Villal\u00f3n CM, Maassenvandenbrink A (2011 Mar) Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects. Pharmacol Ther 129(3):332\u2013351","journal-title":"Pharmacol Ther"},{"issue":"1","key":"979_CR78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/17425255.2018.1416097","volume":"14","author":"A Gonz\u00e1lez-Hern\u00e1ndez","year":"2018","unstructured":"Gonz\u00e1lez-Hern\u00e1ndez A, Marichal-Cancino BA, MaassenVanDenBrink A, Villal\u00f3n CM (2018 Jan) Sideeffects associated with current and prospective antimigraine pharmacotherapies. Expert Opin Drug Metab Toxicol 14(1):25\u201341","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"979_CR79","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s13311-018-0622-7","volume":"15","author":"B Raffaelli","year":"2018","unstructured":"Raffaelli B, Reuter U (2018 Apr) The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy. Neurotherapeutics. 15(2):324\u2013335","journal-title":"Neurotherapeutics."},{"issue":"4","key":"979_CR80","doi-asserted-by":"publisher","first-page":"871","DOI":"10.4161\/mabs.29242","volume":"6","author":"S Walter","year":"2014","unstructured":"Walter S, Alibhoy A, Escandon R, Bigal ME (2014 Aug) Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide. MAbs. 6(4):871\u2013878","journal-title":"MAbs."},{"issue":"12","key":"979_CR81","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/0333102414527646","volume":"34","author":"ME Bigal","year":"2014","unstructured":"Bigal ME, Walter S, Bronson M, Alibhoy A, Escandon R (2014 Oct) Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP. Cephalalgia. 34(12):968\u2013976","journal-title":"Cephalalgia."},{"key":"979_CR82","first-page":"333102417741297","volume":"1","author":"S Khan","year":"2017","unstructured":"Khan S, Olesen A, Ashina M (2017 Jan) CGRP, a target for preventive therapy in migraine and cluster headache: systematic review of clinical data. Cephalalgia. 1:333102417741297","journal-title":"Cephalalgia."},{"issue":"8","key":"979_CR83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11940-017-0463-4","volume":"19","author":"AR Tso","year":"2017","unstructured":"Tso AR, Goadsby PJ (2017 Aug) Anti-CGRP monoclonal antibodies: the next era of migraine prevention? Curr Treat Options Neurol 19(8):27","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"979_CR84","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/head.13316","volume":"58","author":"C Depre","year":"2018","unstructured":"Depre C, Antalik L, Starling A, Koren M, Eisele O, Lenz RA et al (2018 May) A randomized, double-blind, placebo-controlled study to evaluate the effect of Erenumab on exercise time during a treadmill test in patients with stable angina. Headache. 58(5):715\u2013723","journal-title":"Headache."},{"issue":"3","key":"979_CR85","doi-asserted-by":"publisher","first-page":"e020498","DOI":"10.1136\/bmjopen-2017-020498","volume":"27;8","author":"AN Mahmoud","year":"2018","unstructured":"Mahmoud AN, Mentias A, Elgendy AY, Qazi A, Barakat AF, Saad M et al (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 27;8(3):e020498","journal-title":"BMJ Open"},{"issue":"12","key":"979_CR86","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1212\/WNL.0000000000004391","volume":"89","author":"M Ashina","year":"2017","unstructured":"Ashina M, Dodick D, Goadsby PJ, Reuter U, Silberstein S, Zhang F et al (2017 Sep 19) Erenumab (AMG 334) in episodic migraine: interim analysis of an ongoing open-label study. Neurology. 89(12):1237\u20131243","journal-title":"Neurology."}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-019-0979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-019-0979-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-019-0979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:05:08Z","timestamp":1583870708000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-019-0979-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1186\/s10194-019-0979-y","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests related to the content of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"27"}}